TELA Bio/ US8723811084 /
2024-05-07 9:59:56 PM | Chg. +0.33 | Volume | Bid- | Ask- | High | Low |
---|---|---|---|---|---|---|
4.92USD | +7.19% | 4,355 Turnover: 21,075.99 |
-Bid Size: - | -Ask Size: - | 4.96 | 4.56 |
GlobeNewswire
04-15
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need fo...
GlobeNewswire
04-08
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
GlobeNewswire
03-21
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial R...
GlobeNewswire
03-21
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for I...
GlobeNewswire
2023-11-16
TELA Bio to Participate in Piper Sandler’s 35th Annual Healthcare Conference
GlobeNewswire
2023-09-18
TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
GlobeNewswire
2023-08-16
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Recons...
GlobeNewswire
2022-03-16
TELA Bio to Participate in Upcoming Canaccord Genuity Musculoskeletal Conference in Chicago, IL
GlobeNewswire
2022-03-03
TELA Bio Announces U.S. Commercial Launch of SiteGuard™ No Rinse Antimicrobial Solution
GlobeNewswire
2021-11-16
Artios Appoints Nora Brennan to Board of Directors and Audit Committee Chair